| Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection P Ulz, S Perakis, Q Zhou, T Moser, J Belic, I Lazzeri, A Wölfler, A Zebisch, ... Nature communications 10 (1), 4666, 2019 | 219 | 2019 |
| Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma P Johnson, Q Zhou, DY Dao, YMD Lo Nature reviews Gastroenterology & hepatology 19 (10), 670-681, 2022 | 199 | 2022 |
| Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity C Koch, A Kuske, SA Joosse, G Yigit, G Sflomos, S Thaler, DJ Smit, ... EMBO molecular medicine 12 (9), e11908, 2020 | 118 | 2020 |
| Epigenetic analysis of cell-free DNA by fragmentomic profiling Q Zhou, G Kang, P Jiang, R Qiao, WKJ Lam, SCY Yu, MJL Ma, L Ji, ... Proceedings of the National Academy of Sciences 119 (44), e2209852119, 2022 | 60 | 2022 |
| Persistence of ctDNA in patients with breast cancer during neoadjuvant treatment is a significant predictor of poor tumor response Q Zhou, SP Gampenrieder, S Frantal, G Rinnerthaler, CF Singer, D Egle, ... Clinical Cancer Research 28 (4), 697-707, 2022 | 45 | 2022 |
| Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer SO Perakis, S Weber, Q Zhou, R Graf, S Hojas, JM Riedl, A Gerger, ... Esmo Open 5 (5), e000872, 2020 | 37 | 2020 |
| Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs Z Zhou, MJL Ma, RWY Chan, WKJ Lam, W Peng, W Gai, X Hu, SC Ding, ... Proceedings of the National Academy of Sciences 120 (17), e2220982120, 2023 | 35 | 2023 |
| Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer Q Zhou, SO Perakis, P Ulz, S Mohan, JM Riedl, E Talakic, S Lax, M Tötsch, ... Genome Medicine 12, 1-17, 2020 | 31 | 2020 |
| Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients C Suppan, R Graf, S Jahn, Q Zhou, EV Klocker, R Bartsch, A Terbuch, ... British Journal of Cancer 126 (3), 456-463, 2022 | 25 | 2022 |
| Human papillomavirus E7 induces p63 expression to modulate DNA damage response S Eldakhakhny, Q Zhou, EJ Crosbie, BS Sayan Cell Death & Disease 9 (2), 127, 2018 | 25 | 2018 |
| On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer T Moser, J Waldispuehl-Geigl, J Belic, S Weber, Q Zhou, ... NPJ Precision Oncology 4 (1), 30, 2020 | 21 | 2020 |
| Single-stranded DNA library preparation does not preferentially enrich circulating tumor DNA T Moser, P Ulz, Q Zhou, S Perakis, JB Geigl, MR Speicher, E Heitzer Clinical Chemistry 63 (10), 1656-1659, 2017 | 19 | 2017 |
| Pir2/Rnf144b is a potential endometrial cancer biomarker that promotes cell proliferation Q Zhou, S Eldakhakhny, F Conforti, EJ Crosbie, G Melino, BS Sayan Cell death & disease 9 (5), 504, 2018 | 18 | 2018 |
| A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker … M Unseld, J Belic, K Pierer, Q Zhou, T Moser, R Bauer, G Piringer, ... International journal of cancer 148 (6), 1452-1461, 2021 | 16 | 2021 |
| Inference of tumor cell-specific transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection of cancer P Ulz, S Perakis, Q Zhou, T Moser, J Belic, I Lazzeri, A Wlfler, A Zebisch, ... bioRxiv, 2019 | 7 | 2019 |
| Untargeted profiling of cell-free circulating DNA Q Zhou, T Moser, S Perakis, E Heitzer Translational Cancer Research 7 (Suppl 2), 2018 | 7 | 2018 |
| Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity. EMBO Mol Med. 2020; e11908 C Koch, A Kuske, SA Joosse, G Yigit, G Sflomos, S Thaler, DJ Smit, ... | 5 | |
| Genomic origin, fragmentomics, and transcriptional properties of long cell-free DNA molecules in human plasma H Che, P Jiang, LYL Choy, SH Cheng, W Peng, RWY Chan, J Liu, Q Zhou, ... Genome Research 34 (2), 189-200, 2024 | 4 | 2024 |
| Targeting the E3-ubiquitin ligase RNF144B to inhibit proliferation in oestrogen receptor negative endometrial cancer cells Q Zhou, T Jackson, S Elhakdakhny, P Townsend, E Crosbie, B Sayan European Journal of Cancer 1 (61), S168-S169, 2016 | 3 | 2016 |
| Abstract PS4-06: Comparison of liquid biopsy and tissue based detection of PIK3CA mutations in HR positive metastatic breast cancer patients C Suppan, Q Zhou, S Jahn, R Graf, EV Klocker, A Terbuch, K Kashofer, ... Cancer Research 81 (4_Supplement), PS4-06-PS4-06, 2021 | 1 | 2021 |
